83 related articles for article (PubMed ID: 21234456)
1. Peculiarities of proliferation and differentiation of cambial and daughter cells of epidermal-dermal morphofunctional zone in normal epithelium and in cancer.
Yavisheva TM; Shcherbakov SD
Bull Exp Biol Med; 2010 Oct; 149(4):521-6. PubMed ID: 21234456
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of proliferation and differentiation of cambial and daughter cells in morphofunctional zones in the normal epithelium and cancer using age aspect].
Iavisheva TM; Shcherbakov SD
Adv Gerontol; 2009; 22(4):605-13. PubMed ID: 20405727
[TBL] [Abstract][Full Text] [Related]
3. Age-specific morphofunctional changes in cambial cells and their derivatives in human skin.
Yavisheva TM; Shcherbakov SD
Bull Exp Biol Med; 2009 Sep; 148(3):437-40. PubMed ID: 20396707
[TBL] [Abstract][Full Text] [Related]
4. [Melanoma and cancer emergence in persons of 20-60 years against normal quantity of cambial cells in morphofunctional zones].
Iavisheva TM; Shchebakov SD
Adv Gerontol; 2014; 27(4):753-7. PubMed ID: 25946855
[TBL] [Abstract][Full Text] [Related]
5. Interaction of cambial dermal cells (fibroblasts) and epidermis in morphofunctional area of mouse skin.
Yavisheva TM; Shcherbakov SD; Golubeva IS; Sharafutdinov GZ
Bull Exp Biol Med; 2007 Nov; 144(5):748-53. PubMed ID: 18683514
[TBL] [Abstract][Full Text] [Related]
6. [Participation of morphofunctional zones in aging processes].
Iavisheva TM; Shcherbakov SD
Adv Gerontol; 2012; 25(4):604-11. PubMed ID: 23734504
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of the work of morphofunctional zones in normal epithelium, fibroadenoma, and cancer of the breast.
Yavisheva TM; Shcherbakov SD; Golubeva IS; Savluchinskaya LA
Bull Exp Biol Med; 2005 Aug; 140(2):231-4. PubMed ID: 16283009
[TBL] [Abstract][Full Text] [Related]
8. Structural organization of the basal layer and morphofunctional characteristics of mouse epidermal cambial cells.
Yavisheva TM; Shcherbakov SD; Golubeva IS; Sharafutdinov GZ; Savluchinskaya LA
Bull Exp Biol Med; 2004 May; 137(5):513-6. PubMed ID: 15455132
[TBL] [Abstract][Full Text] [Related]
9. On the common mechanisms of cambial somatic and sex cells proliferation and the notion of the cambial cells.
Yavisheva TM; Shcherbakov SD
Bull Exp Biol Med; 2012 May; 153(1):82-5. PubMed ID: 22808500
[TBL] [Abstract][Full Text] [Related]
10. Peculiarities of proliferation of epidermal cambial cells in mouse skin.
Yavisheva TM; Shcherbakov SD; Dubinkin IV
Bull Exp Biol Med; 2005 Jul; 140(1):118-21. PubMed ID: 16254636
[TBL] [Abstract][Full Text] [Related]
11. The small peptide OGP(10-14) acts through Src kinases and RhoA pathways in Mo-7e cells: morphologic and immunologic evaluation.
Mattii L; Battolla B; Moscato S; Fazzi R; Galimberti S; Bernardini N; Dolfi A; Petrini M
Med Sci Monit; 2008 Jun; 14(6):BR103-108. PubMed ID: 18509267
[TBL] [Abstract][Full Text] [Related]
12. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
13. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
[TBL] [Abstract][Full Text] [Related]
15. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
16. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
[TBL] [Abstract][Full Text] [Related]
17. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation.
Aznar S; Valerón PF; del Rincon SV; Pérez LF; Perona R; Lacal JC
Mol Biol Cell; 2001 Oct; 12(10):3282-94. PubMed ID: 11598209
[TBL] [Abstract][Full Text] [Related]
19. SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane.
Machiyama H; Yamaguchi T; Sawada Y; Watanabe TM; Fujita H
FEBS J; 2015 Oct; 282(20):4034-55. PubMed ID: 26258764
[TBL] [Abstract][Full Text] [Related]
20. Crk Tyrosine Phosphorylation Regulates PDGF-BB-inducible Src Activation and Breast Tumorigenicity and Metastasis.
Kumar S; Lu B; Davra V; Hornbeck P; Machida K; Birge RB
Mol Cancer Res; 2018 Jan; 16(1):173-183. PubMed ID: 28974561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
